Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
ASCO24
Jun 1, 2024, 21:24 |
Blog
IMG Oncologists - Karun Neupane presenting the Research and Publications Committee of ASCO IMG CoP
Karun Neupane, Internal Medicine resident at Albert Einstein College of Medicine, shared a post by IMG…
Jun 1, 2024, 12:46 |
Blog
Saad Nasir: Experiencing my first ASCO meeting
Saad Nasir,Medical Oncology resident at Aga Khan University Hospital, shard on their X: "Excited to…
Jun 1, 2024, 12:41 |
Blog
Sumanta K. Pal: Loved this interview with Toni Choueiri in the The ASCO Post
Sumanta K. Pal shared a post on X: "Loved this interview with Toni Choueiri in the…
Jun 1, 2024, 12:35 |
Insight
Duaa Kanan: Check out our abstract on the role of CPS for PD-L1 expression in patients with NSCLC
Duaa Kanan, Internal Medicine Resident Physician at the University of Illinois College of Medicine Peoria,…
Jun 1, 2024, 12:12 |
Societies
Chris Boshoff: Pfizer announced a 5-year update from our Phase 3 study for patients with ALK+ advanced NSCLC
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, shared on LinkedIn: "Today…
Jun 1, 2024, 11:24 |
Blog
Narjust Florez: It is not only about living longer but also living well for our patients
Narjust Florez shared a post by Shankar Siva, Professor, Faculty of Medicine at University of Melbourne on…
Jun 1, 2024, 10:54 |
Blog
Pashtoon Kasi: This month’s enrollments to therapeutic studies at Weill Cornell Medicine New York-Presbyterian Hospital
Pashtoon Kasi shared on LinkedIn: "Importance of enrolling in interventional clinical trials cannot be overemphasized. This…
Jun 1, 2024, 10:54 |
Blog
Wafik El-Deiry: Delighted to visit with Bayer Pharmaceuticals in Boston
Wafik El-Deiry recently shared on LinkedIn: "Delighted to visit with Bayer Pharmaceuticals in Boston for discussions…
Jun 1, 2024, 10:17 |
Blog
Hidehito Horinouchi: HARMONi-A - Chemo +/- Ivonescimab in EGFRm NSCLC after EGFR-TKIs resistance
Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital,…
Jun 1, 2024, 07:36 |
Blog
Phuong Ly-Gallagher: Come join ASCO Voices session!
Phuong Ly-Gallagher, Research Advocate Training and Support (RATS) Manager at Fight Colorectal Cancer, shared on LinkedIn:…
55
56
57
58
59
All:
677
Posts:
561 - 570
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube